Oramed Pharmaceuticals
ORMPOramed Pharmaceuticals, or Oramed (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem, Israel. Its shares are lis …
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Oramed Pharmaceuticals
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 7/1/2026 | Sell | $4.5 | $330,744 |
| 7/1/2026 | Sell | $4.5 | $611,431 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)